Page last updated: 2024-08-21

dihydroergotamine and Deep Vein Thrombosis

dihydroergotamine has been researched along with Deep Vein Thrombosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gelfand, AA; Goadsby, PJ; Patniyot, IR; Tso, AR1
Adekoya-Cole, TO; Enweluzo, GO; Giwa, SO; Obalum, DC; Ogo, CN1

Reviews

1 review(s) available for dihydroergotamine and Deep Vein Thrombosis

ArticleYear
Deep vein thrombosis: risk factors and prevention in surgical patients.
    West African journal of medicine, 2009, Volume: 28, Issue:2

    Topics: Anticoagulants; Aspirin; Awareness; Clinical Competence; Cyclooxygenase Inhibitors; Dextrans; Dihydroergotamine; Fibrinolytic Agents; Heparin; Humans; Nigeria; Postoperative Complications; Risk Factors; Vasoconstrictor Agents; Venous Thrombosis; Warfarin

2009

Other Studies

1 other study(ies) available for dihydroergotamine and Deep Vein Thrombosis

ArticleYear
Increased rate of venous thrombosis may be associated with inpatient dihydroergotamine treatment.
    Neurology, 2017, Jul-18, Volume: 89, Issue:3

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Catheters, Indwelling; Child; Dihydroergotamine; Female; Humans; Incidence; Inpatients; Lidocaine; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Tertiary Care Centers; Venous Thrombosis; Young Adult

2017